American Healthcare REIT, Inc. (AHR)

American Healthcare REIT Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 33.33, with a low estimate of 29 and a high estimate of 37. The average target predicts an increase of 10.05% from the current stock price of 30.29.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$33.33	$34	$37
Change	-4.24%	+10.05%	+12.27%	+22.17%

Analyst Ratings

The average analyst rating for American Healthcare REIT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	2	2
Buy	5	5	5	5	4	4
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Austin Wurschmidt Keybanc	Keybanc	Buy Maintains $35 → $34	Buy	Maintains	$35 → $34	+12.27%	Mar 31, 2025
Ronald Kamdem Morgan Stanley	Morgan Stanley	Buy Maintains $36 → $37	Buy	Maintains	$36 → $37	+22.17%	Mar 25, 2025
Michael Carroll RBC Capital	RBC Capital	Buy Reiterates $34	Buy	Reiterates	$34	+12.27%	Mar 19, 2025
Aaron Hecht Citizens Capital Markets	Citizens Capital Markets	Buy Maintains $30 → $35	Buy	Maintains	$30 → $35	+15.57%	Mar 4, 2025
Ronald Kamdem Morgan Stanley	Morgan Stanley	Buy Maintains $27 → $29	Buy	Maintains	$27 → $29	-4.24%	Dec 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.23B

Increased by 8.10%

from 2.06B

Revenue Next Year

2.37B

Increased by 6.36%

from 2.23B

EPS This Year

0.41

from -0.29

EPS Next Year

0.59

Increased by 45.96%

from 0.41

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.18B	1.26B	1.62B	1.86B	2.06B	2.23B	2.37B	2.71B
Revenue Growth	-2.98%	6.70%	28.08%	14.73%	11.11%	8.10%	6.36%	14.33%
EPS	0.05	-0.95	-1.24	-1.08	-0.29	0.41	0.59	0.80
EPS Growth	-	-	-	-	-	-	45.96%	34.47%
Forward PE	-	-	-	-	-	74.50	51.04	37.96
No. Analysts	-	-	-	-	-	5	5	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	2.4B	2.6B	2.9B
Avg	2.2B	2.4B	2.7B
Low	2.1B	2.1B	2.6B

Revenue Growth

Revenue Growth	2025	2026	2027
High	16.8%	18.6%	21.6%
Avg	8.1%	6.4%	14.3%
Low	0.2%	-4.3%	8.4%

EPS Forecast

EPS	2025	2026	2027
High	0.60	0.75	0.83
Avg	0.41	0.59	0.80
Low	0.26	0.47	0.77

EPS Growth

EPS Growth	2025	2026	2027
High	-	83.4%	39.8%
Avg	-	46.0%	34.5%
Low	-	15.7%	30.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.